Radiolabeled FAPI
摘要
This chapter describes the interesting role of PET with radiolabeled fibroblast activation protein inhibitors (FAPIs), underlining the potential clinical indications. Furthermore, the emerging role of FAPI PET is highlighted with interesting clinical cases. In addition synthesis, pharmacokinetics and physiological distribution of FAPIs, and PET acquisition protocols are described as well.